Magellan Laboratories Announces 2001 Growth Strategy

Research Triangle Park, NC - Magellan Laboratories, a provider of a complete spectrum of contract pharmaceutical development services, has announced growth plans for 2001. Now entering its tenth year, the company finds itself in the enviable position of having to plan for an increase in business demand of at least 25% this year.

Magellan Laboratories entered the field in 1991 with the vision of creating an environment in which the highest levels of scientific excellence would facilitate efficient, timely and profitable drug development protocols for its customers. Recruiting a team of leading scientists with a track record of innovative thinking, and developing communications channels that support collaborative customer relationships, are the two pillars of Magellan's mission.

The rapid pace of the pharmaceutical industry-with all of the stresses of global competition-has opened many new opportunities for the contract laboratory industry. Now employing over 425 people, and with the added strength of a facility in San Diego, California, Magellan is in a particularly strong position to anticipate and satisfy new demands.

Each of Magellan's seven divisions is continually being strengthened, but as 2001 unfolds, special emphasis is being placed on:

• Stability Studies - increased capacity and streamlined computerized systems
• Pharmaceutics - preformulation and formulation of solids, parenterals, topicals, and inhalation products
• Comparators - dedicated analytical group
• Synthesis - expansion into 5-7 kg scale for APIs
• Structural Chemistry - increased MS capacity, and a new NMR facility
• Raw Materials - rapid, efficient release of raw materials

Eric Hoffman, Vice President of Business Development says, "This is truly an exciting time for us at Magellan. We can now partner with our customers in completing the full range of new drug development activities or in assuming ongoing projects midstream." Mr. Hoffman can be reached at 1-919-481-4855 or by e-mail at info@magellanlabs.com.